Target-based Classification of Drugs

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
   Serine/threonine kinases
   Receptor serine/threonine kinases (RSTK)
   Receptor tyrosine kinases (RTK)
   Non-receptor tyrosine kinases
     SRC family
     ABL family
     SYK family
     JAK family
       JAK1 [HSA:3716] [KO:K11217]
         D09959  Ruxolitinib (USAN/INN)
         D09960  Ruxolitinib phosphate (JAN/USAN) <JP/US>
         D09970  Tofacitinib (USAN)
         D09783  Tofacitinib citrate (JAN/USAN) <JP/US>
         D10308  Baricitinib (JAN/USAN/INN) <JP/US>
         D10994  Upadacitinib (USAN/INN)
         D10995  Upadacitinib tartrate (USAN)
         D11048  Upadacitinib hydrate (JAN) <JP/US>
         D10141  Oclacitinib (USAN)
         D10142  Oclacitinib maleate (USAN)
         D10315  Momelotinib (USAN/INN)
         D10358  Momelotinib dihydrochloride (USAN)
         D10653  Peficitinib (USAN/INN)
         D10721  Peficitinib hydrobromide (JAN/USAN) <JP>
         D10728  Solcitinib (USAN/INN)
         D10871  Filgotinib (USAN/INN)
         D10872  Filgotinib hydrochloride (USAN)
         D10889  Momelotinib hydrochloride hydrate (JAN)
         D10944  Itacitinib (USAN/INN)
         D10945  Itacitinib adipate (JAN/USAN)
         D11046  Delgocitinib (JAN/USAN) <JP>
         D11106  Filgotinib maleate (JAN/USAN) <JP>
         D11400  Abrocitinib (JAN/USAN)
         D11537  Brepocitinib (USAN)
         D11538  Brepocitinib tosylate (USAN)
         D11676  Gusacitinib (USAN/INN)
         D11677  Gusacitinib hydrochloride (USAN)
         D11866  Deuruxolitinib (USAN)
         D11867  Deuruxolitinib phosphate (USAN)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       JAK2 [HSA:3717] [KO:K04447]
         D09959  Ruxolitinib (USAN/INN)
         D09960  Ruxolitinib phosphate (JAN/USAN) <JP/US>
         D10630  Fedratinib (USAN/INN)
         D11296  Fedratinib hydrochloride (USAN) <US>
         D09970  Tofacitinib (USAN)
         D09783  Tofacitinib citrate (JAN/USAN) <JP/US>
         D10308  Baricitinib (JAN/USAN/INN) <JP/US>
         D10315  Momelotinib (USAN/INN)
         D10358  Momelotinib dihydrochloride (USAN)
         D10365  Gandotinib (USAN)
         D10653  Peficitinib (USAN/INN)
         D10721  Peficitinib hydrobromide (JAN/USAN) <JP>
         D10889  Momelotinib hydrochloride hydrate (JAN)
         D11046  Delgocitinib (JAN/USAN) <JP>
         D11106  Filgotinib maleate (JAN/USAN) <JP>
         D11599  Zotiraciclib (USAN)
         D11600  Zotiraciclib citrate (USAN)
         D11676  Gusacitinib (USAN/INN)
         D11677  Gusacitinib hydrochloride (USAN)
         D11768  Pacritinib (USAN/INN)
         D11866  Deuruxolitinib (USAN)
         D11867  Deuruxolitinib phosphate (USAN)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       JAK3 [HSA:3718] [KO:K11218]
         D09970  Tofacitinib (USAN)
         D09783  Tofacitinib citrate (JAN/USAN) <JP/US>
         D10585  Decernotinib (USAN/INN)
         D10653  Peficitinib (USAN/INN)
         D10721  Peficitinib hydrobromide (JAN/USAN) <JP>
         D11046  Delgocitinib (JAN/USAN) <JP>
         D11106  Filgotinib maleate (JAN/USAN) <JP>
         D11676  Gusacitinib (USAN/INN)
         D11677  Gusacitinib hydrochloride (USAN)
 
 
 
 
 
 
 
 
 
       TYK2 [HSA:7297] [KO:K11219]
     FAK family
     Tec family
     InsR family
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
 
 Transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 20, 2020

» Japanese version